EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells

Ren-Jun Hsu iD, Cheng-Shuo Huang iD, Ming-Kung Yeh, Zheng-Zong Lai iD, Cheng-Ping Yu iD, Jar-Yi Ho iD, Fung-Wei Chang iD

International Journal of Molecular Sciences · 28.06.2026 · 27 (13) · 5842

DOI: 10.3390/ijms27135842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.06.2026. Verfasst von Ren-Jun Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan. Hauptthemen laut MEDLINE: Cisplatin, Endometrial Neoplasms, Mesenchymal Stem Cells, Extracellular Vesicles. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tri-Service General Hospital, Tzu Chi Foundation, Hualien Tzu Chi Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (cis-diamminedichloroplatinum(II) [DDP]) is a key chemotherapeutic agent for advanced endometrial cancer; however, chemoresistance substantially limits its clinical benefit. Extracellular vesicles (EVs) mediate intercellular communication and influence tumour cell behaviour and therapeutic response. We investigated whether mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) and natural killer cell-derived extracellular vesicles (NK-EVs) modulate cisplatin responsiveness in endometrial cancer cells (RL95-2 and HEC-1A). MSC-EVs and NK-EVs were isolated and characterised using nanoparticle tracking analysis, scanning electron microscopy, and EV marker profiling. MSC-EVs and NK-EVs reduced RL95-2 and HEC-1A cell viability in a dose-dependent manner, with MSC-EVs exhibiting substantial effects at lower particle concentrations. In a cisplatin-resistant HEC-1A (HEC-1A DDP-R) model, MSC-EVs were associated with greater reductions in cell viability under cisplatin treatment conditions, whereas NK-EVs showed comparatively modest effects. Mechanistic analyses demonstrated altered expression of apoptosis- and cell cycle–related proteins, including increased cleaved poly(ADP-ribose) polymerase and cleaved caspase-3 levels and reduced cyclin A and cyclin D1 expression following MSC-EV treatment. Annexin V-fluorescein isothiocyanate/propidium iodide flow cytometry demonstrated increased apoptotic cell populations after MSC-EV treatment, with MSC-EV + DDP co-treatment resulting in the highest apoptotic fraction in chemoresistant HEC-1A cells. Collectively, these findings indicate that MSC-EVs are associated with altered cellular responses to cisplatin in chemoresistant endometrial cancer cells, accompanied by changes in apoptosis-related protein expression, apoptotic cell populations, and cell-cycle regulators. Further investigation is required to determine their mechanistic role and therapeutic potential in overcoming chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinEndometrial NeoplasmsMesenchymal Stem CellsExtracellular VesiclesKiller Cells, NaturalAntineoplastic AgentsFemaleHumansCell Line, TumorApoptosisDrug Resistance, NeoplasmCell Survival

Stichwörter der Autor:innen

apoptosiscell-cycle regulationcisplatin resistanceendometrial cancerextracellular vesicles

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Cancer Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan.
  • School of Medicine, Tzu Chi University, Hualien 970374, Taiwan.
  • Department of BioMedical Engineering, Ming Chuan University, Taoyuan 333321, Taiwan.
  • Graduate Institute of Life Sciences, College of Biomedical Sciences, National Defense Medical University, Taipei 114, Taiwan.
  • Graduate Institute of Pathology and Parasitology, College of Medicine, National Defense Medical University, Taipei 114, Taiwan.
  • Department of Pathology, Tri-Service General Hospital, National Defense Medical University, Taipei 114, Taiwan.

ORCID-Profile: Ren-Jun Hsu, Cheng-Shuo Huang, Zheng-Zong Lai, Cheng-Ping Yu, Jar-Yi Ho, Fung-Wei Chang

Förderung

  • Tri-Service General Hospital
  • Tzu Chi Foundation
  • Hualien Tzu Chi Medical Center
  • Tri-Service General Hospital Penghu Branch
  • Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
  • Teh-Tzer Study Group for Human Medical Research Foundation
  • Hualien Tzu Chi Hospital and Buddhist Tzu Chi Medical Foundation

Zitieren

APA

Hsu, R. J., Huang, C. S., Yeh, M. K., Lai, Z. Z., Yu, C. P., Ho, J. Y., & Chang, F. W. (2026). Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells. International Journal of Molecular Sciences, 27(13), 5842. https://doi.org/10.3390/ijms27135842

Vancouver

Hsu RJ, Huang CS, Yeh MK, Lai ZZ, Yu CP, Ho JY, et al. Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells. International Journal of Molecular Sciences. 2026;27(13):5842. doi:10.3390/ijms27135842

BibTeX
@article{Hsu2026,
  author = {Hsu, Ren-Jun and Huang, Cheng-Shuo and Yeh, Ming-Kung and Lai, Zheng-Zong and Yu, Cheng-Ping and Ho, Jar-Yi and Chang, Fung-Wei},
  title = {Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5842},
  doi = {10.3390/ijms27135842}
}
Kostenlos starten →